UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 179

Sortiert nach

Residual cognitive and psychosocial functional impairment in outpatients in Greece who responded to conventional antidepressant monotherapy treatments for major depressive disorder (MDD)

Journal of affective disorders, 2022-10, Vol.314, p.185-192

2022

Volltextzugriff (PDF)

Visual memory deficits and symptoms in schizophrenia

European psychiatry, 2016-03, Vol.33, p.S301-S302

2016

Volltextzugriff (PDF)

Is clinical global impression associated with intelligence in schizophrenia?

European psychiatry, 2016-03, Vol.33, p.S302-S302

2016

Volltextzugriff (PDF)

COMT polymorphisms and Mini-Mental State Examination performance in schizophrenia

European psychiatry, 2016-03, Vol.33, p.S302-S302

2016

Volltextzugriff (PDF)

P.3.f.001 Catechol-O-methyltransferase [rs4680] and methylenetetrahydrofolate reductase [rs1801133] polymorphisms interact on elevated plasma homocysteine in schizophrenia

European neuropsychopharmacology, 2013-10, Vol.23, p.S492-S492

2013

Volltextzugriff (PDF)

Contrasting patterns of deficits in visuospatial memory and executive function in patients with major depression with and without ECT referral

Psychological medicine, 2011-05, Vol.41 (5), p.983-995

2011

Volltextzugriff (PDF)

Dopamine in anorexia nervosa: a systematic review

Behavioural pharmacology, 2012-09, Vol.23 (5-6), p.496

2012

Volltextzugriff (PDF)

The association of schizophrenia symptoms clusters with obsessive compulsive symptoms

European psychiatry, 2017-04, Vol.41 (S1), p.S385-S386

2017

Volltextzugriff (PDF)

Obsessive compulsive symptoms, social functioning and executive functions in chronic schizophrenia

European psychiatry, 2017-04, Vol.41 (S1), p.S386-S386

2017

Volltextzugriff (PDF)

P.330 Functioning and functional recovery in outpatients with major depressive disorder in Greece treated with vortioxetine

European neuropsychopharmacology, 2020-11, Vol.40, p.S192-S193

2020

Volltextzugriff (PDF)

P03-252 - Cognitive complaints in schizophrenia are associated with clinical symptoms and global functioning but not actual cognitive performance

European psychiatry, 2011, Vol.26, p.1421-1421

2011

Volltextzugriff (PDF)

P.3.c.042 Antipsychotic polypharmacy and excessive doses are not associated with attentional flexibility in schizophrenia

European neuropsychopharmacology, 2010, Vol.20, p.S482-S482

2010

Volltextzugriff (PDF)

P02-551 - Clinically effective ect treatment restores visuospatial learning / memory but not attentional flexibility deficits in patients with major depression

European psychiatry, 2011, Vol.26, p.1147-1147

2011

Volltextzugriff (PDF)

P02-550 - Double dissociation of deficits in visuospatial memory and executive function in patients with major depression with and without ECT referral

European psychiatry, 2011, Vol.26, p.1146-1146

2011

Volltextzugriff (PDF)

P03-78 - No effects of polypharmacy and antipsychotic dose on spatial working memory in schizophrenia

European psychiatry, 2010, Vol.25 (S1), p.1200-1200, Article 25-E1188

2010

Volltextzugriff (PDF)

181 – Adolescent brain growth and psychosis-proneness

Schizophrenia research, 2008-02, Vol.98, p.107-108

2008

Volltextzugriff (PDF)

192 – White matter and cognitive performance in preterm and term-born adults

Schizophrenia research, 2008-02, Vol.98, p.112-112

2008

Volltextzugriff (PDF)

Plasma antioxidants in schizophrenia and manic relapse

European psychiatry, 2008-04, Vol.23, p.S136-S137

2008

Volltextzugriff (PDF)

Serum lipid levels in schizophrenia and bipolar disorder relapse

European psychiatry, 2008-04, Vol.23, p.S136-S136

2008

Volltextzugriff (PDF)

Prevalence of Hepatitis B and C markers in psychiatric patients

European psychiatry, 2008-04, Vol.23, p.S278-S278

2008

Volltextzugriff (PDF)

P03-32 Directional persistence in the rewarded alternation model of obsessive-compulsive disorder is responsive to both dopaminergic and serotonergic manipulations

European psychiatry, 2009, Vol.24, p.S1031-S1031

2009

Volltextzugriff (PDF)

P03-33 An investigation of 5-HT2 involvement in the acute behavioural effects of fluoxetine and mCPP in an animal model of OCD

European psychiatry, 2009, Vol.24, p.S1032-S1032

2009

Volltextzugriff (PDF)

Functional recovery in patients with major depressive disorder (MDD) – the role of cognitive symptoms in real life clinical practice

European neuropsychopharmacology, 2017-10, Vol.27, p.S862

2017

Volltextzugriff (PDF)

P.2.f.029 - Functional recovery in patients with major depressive disorder (MDD) – the role of cognitive symptoms in real life clinical practice

European neuropsychopharmacology, 2017-10, Vol.27, p.S862-S862

2017

Volltextzugriff (PDF)

THE “MELETI” COGNITIVE REHABILITATION PROGRAMME: CLINICAL AND NEUROPSYCHOLOGICAL ASSESSMENT OF PARTICIPANTS

Dialogues in Clinical Neuroscience & Mental Health (Online), 2018-10, Vol.1 (s3)

2018

Volltextzugriff (PDF)

1 – 25 von 179

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(113)
Mit Volltextzugriff
(123)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(60)
Humans
(36)
Life Sciences & Biomedicine
(36)
Surgery
(26)
Male
(23)
Technology
(23)
Female
(22)
Psychiatry
(21)
Internal Medicine
(17)
Adult
(15)
History & Archaeology
(14)
Engineering
(13)
Middle Aged
(13)
Aged
(11)
Archaeology
(11)
History
(11)
Engineering, Electrical & Electronic
(10)
Archéologie Du Bâti
(9)
Biological And Medical Sciences
(9)
Cosmetic Techniques
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Residual cognitive and psychosocial functional impairment in outpatients in Greece who responded to conventional antidepressant monotherapy treatments for major depressive disorder (MDD)

Visual memory deficits and symptoms in schizophrenia

Is clinical global impression associated with intelligence in schizophrenia?

COMT polymorphisms and Mini-Mental State Examination performance in schizophrenia

P.3.f.001 Catechol-O-methyltransferase [rs4680] and methylenetetrahydrofolate reductase [rs1801133] polymorphisms interact on elevated plasma homocysteine in schizophrenia

Contrasting patterns of deficits in visuospatial memory and executive function in patients with major depression with and without ECT referral

Dopamine in anorexia nervosa: a systematic review

The association of schizophrenia symptoms clusters with obsessive compulsive symptoms

Obsessive compulsive symptoms, social functioning and executive functions in chronic schizophrenia

P.330 Functioning and functional recovery in outpatients with major depressive disorder in Greece treated with vortioxetine

P03-252 - Cognitive complaints in schizophrenia are associated with clinical symptoms and global functioning but not actual cognitive performance

P.3.c.042 Antipsychotic polypharmacy and excessive doses are not associated with attentional flexibility in schizophrenia

P02-551 - Clinically effective ect treatment restores visuospatial learning / memory but not attentional flexibility deficits in patients with major depression

P02-550 - Double dissociation of deficits in visuospatial memory and executive function in patients with major depression with and without ECT referral

P03-78 - No effects of polypharmacy and antipsychotic dose on spatial working memory in schizophrenia

181 – Adolescent brain growth and psychosis-proneness

192 – White matter and cognitive performance in preterm and term-born adults

Plasma antioxidants in schizophrenia and manic relapse

Serum lipid levels in schizophrenia and bipolar disorder relapse

Prevalence of Hepatitis B and C markers in psychiatric patients

P03-32 Directional persistence in the rewarded alternation model of obsessive-compulsive disorder is responsive to both dopaminergic and serotonergic manipulations

P03-33 An investigation of 5-HT2 involvement in the acute behavioural effects of fluoxetine and mCPP in an animal model of OCD

Functional recovery in patients with major depressive disorder (MDD) – the role of cognitive symptoms in real life clinical practice

P.2.f.029 - Functional recovery in patients with major depressive disorder (MDD) – the role of cognitive symptoms in real life clinical practice

THE “MELETI” COGNITIVE REHABILITATION PROGRAMME: CLINICAL AND NEUROPSYCHOLOGICAL ASSESSMENT OF PARTICIPANTS

Suchergebnisse filtern